Loading…

Axonal excitability changes and acute symptoms of oxaliplatin treatment: In vivo evidence for slowed sodium channel inactivation

•Symptoms after oxaliplatin infusion correlate with nerve excitability findings.•Oxaliplatin induces a slowing of sodium channel inactivation in motor nerve fibres.•Motor nerve superexcitability may be a good biomarker of acute oxaliplatin neurotoxicity. Neurotoxicity is the most frequent dose-limit...

Full description

Saved in:
Bibliographic Details
Published in:Clinical neurophysiology 2018-03, Vol.129 (3), p.694-706
Main Authors: Heide, Rikke, Bostock, Hugh, Ventzel, Lise, Grafe, Peter, Bergmans, Joseph, Fuglsang-Frederiksen, Anders, Finnerup, Nanna B., Tankisi, Hatice
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Symptoms after oxaliplatin infusion correlate with nerve excitability findings.•Oxaliplatin induces a slowing of sodium channel inactivation in motor nerve fibres.•Motor nerve superexcitability may be a good biomarker of acute oxaliplatin neurotoxicity. Neurotoxicity is the most frequent dose-limiting side effect of the anti-cancer agent oxaliplatin, but the mechanisms are not well understood. This study used nerve excitability testing to investigate the pathophysiology of the acute neurotoxicity. Questionnaires, quantitative sensory tests, nerve conduction studies and nerve excitability testing were undertaken in 12 patients with high-risk colorectal cancer treated with adjuvant oxaliplatin and in 16 sex- and age-matched healthy controls. Examinations were performed twice for patients: once within 3 days after oxaliplatin treatment (post-infusion examination) and once shortly before the following treatment (recovery examination). The most frequent post-infusion symptoms were tingling paresthesias and cold allodynia. The most prominent nerve excitability change was decreased superexcitability of motor axons which correlated with the average intensity of abnormal sensations (Spearman Rho = 0.80, p 
ISSN:1388-2457
1872-8952
DOI:10.1016/j.clinph.2017.11.015